A single-nucleotide polymorphism of miR-146a and psoriasis: An association and functional study

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 11, 2014, Pages 2225-2234

  Zhang, Weigang ^a   Yi, Xiuli ^a   Guo, Sen ^a   Shi, Qiong ^a   Wei, Chao ^a   Li, Xia ^a   Gao, Lin ^a   Wang, Gang ^a   Gao, Tianwen ^a   Wang, Lei ^a   Li, Chunying ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

EGFR; SNP; MicroRNA; MiR 146a; Psoriasis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA; MIRN146 MICRORNA, HUMAN;

ADULT; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PSORIASIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK FACTORS;

EID: 84911020277     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12359     Document Type: Article

References (34)

1. Parisi R, Symmons DP, Griffiths CE, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013; 133: 377-85.
2. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009; 361: 496-509.
3. Perera GK, Di Meglio P, Nestle FO. Psoriasis. Annu Rev Pathol. 2012; 7: 385-422.
4. Murphy M, Kerr P, Grant-Kels JM. The histopathologic spectrum of psoriasis. Clin Dermatol. 2007; 25: 524-8.
5. Tschachler E. Psoriasis: the epidermal component. Clin Dermatol. 2007; 25: 589-95.
6. Nanney LB, Stoscheck CM, Magid M, et al. Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol. 1986; 86: 260-5.
7. Wu NL, Huang DY, Hsieh SL, et al. EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis. Biochim Biophys Acta. 2013; 1832: 1538-48.
8. Meyer-Hoffert U, Wingertszahn J, Wiedow O. Human leukocyte elastase induces keratinocyte proliferation by epidermal growth factor receptor activation. J Invest Dermatol. 2004; 123: 338-45.
9. Ben-Bassat H. Biological activity of tyrosine kinase inhibitors: novel agents for psoriasis therapy. Curr Opin Investig Drugs. 2001; 2: 1539-45.
10. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008; 9: 102-14.
11. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281-97.
12. Cai Y, Yu X, Hu S, et al. A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics. 2009; 7: 147-54.
13. Gong J, Tong Y, Zhang HM, et al. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat. 2012; 33: 254-63.
14. Gao LB, Bai P, Pan XM, et al. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2011; 125: 571-4.
15. Xing J, Wan S, Zhou F, et al. Genetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2012; 21: 217-27.
16. Huang Y, Yi X, Jian Z, et al. A single-nucleotide polymorphism of miR-196a-2 and vitiligo: an association study and functional analysis in a Han Chinese population. Pigment Cell Melanoma Res. 2013; 26: 338-47.
17. Shen J, Ambrosone CB, DiCioccio RA, et al. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis. 2008; 29: 1963-6.
18. Jazdzewski K, Murray EL, Franssila K, et al. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA. 2008; 105: 7269-74.
19. Xu B, Feng NH, Li PC, et al. A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. Prostate. 2010; 70: 467-72.
20. Wei WJ, Wang YL, Li DS, et al. Association between the rs2910164 polymorphism in pre-Mir-146a sequence and thyroid carcinogenesis. PLoS ONE. 2013; 8: e56638.
21. Gazouli M, Papaconstantinou I, Stamatis K, et al. Association study of genetic variants in miRNAs in patients with inflammatory bowel disease: preliminary results. Dig Dis Sci. 2013; 58: 2324-8.
22. Chen HF, Hu TT, Zheng XY, et al. Association between miR-146a rs2910164 polymorphism and autoimmune diseases susceptibility: a meta-analysis. Gene. 2013; 521: 259-64.
23. Kogo R, Mimori K, Tanaka F, et al. Clinical significance of miR-146a in gastric cancer cases. Clin Cancer Res. 2011; 17: 4277-84.
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25: 402-8.
25. Duan R, Pak C, Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet. 2007; 16: 1124-31.
26. Xu B, Wang N, Wang X, et al. MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer. Prostate. 2012; 72: 1171-8.
27. Xu N, Brodin P, Wei T, et al. MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. J Invest Dermatol. 2011; 131: 1521-9.
28. Xu N, Meisgen F, Butler LM, et al. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J Immunol. 2013; 190: 678-88.
29. Guo S, Zhang W, Wei C, et al. Serum and skin levels of miR-369-3p in patients with psoriasis and their correlation with disease severity. Eur J Dermatol. 2013; 23: 608-13.
30. Sonkoly E, Wei T, Janson PC, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS ONE. 2007; 2: e610.
31. Joyce CE, Zhou X, Xia J, et al. Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum Mol Genet. 2011; 20: 4025-40.
32. Xia P, Fang X, Zhang ZH, et al. Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions. Immunol Lett. 2012; 148: 151-62.
33. Mishra PJ, Mishra PJ, Banerjee D, et al. MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: introducing microRNA pharmacogenomics. Cell Cycle. 2008; 7: 853-8.
34. Liu Z, Li G, Wei S, et al. Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer. 2010; 116: 4753-60.